Report Detail
Global Bi-Specific Antibodies Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029
- RnM4528948 |
- 13 April, 2023 |
- Global |
- 102 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
A bispecific antibody (BsAb), or specific monoclonal antibody (BsMAb) is an artificial protein comprised of fragments from two different antibodies. By virtue of the inclusion of two different antigen binding regions, a bispecific antibody is capable of recognizing and binding to two different antigens, or two different epitope on an antigen.
According to our (Global Info Research) latest study, the global Bi-Specific Antibodies Therapy market size was valued at USD 3360.6 million in 2022 and is forecast to a readjusted size of USD 16260 million by 2029 with a CAGR of 25.3% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Bi-Specific Antibodies Therapy key players include Roche, Amgen, Sanofi, Pfizer, Johnson & Johnson, etc. Global top five manufacturers hold a share over 95%.
North America is the largest market, with a share about 65%, followed by Europe and China, both have a share over 30 percent. In terms of product, IgG-Based Antibodies is the largest segment, with a share over 85%. And in terms of application, the largest application is Haemophilia, followed by Cancer, etc.
This report is a detailed and comprehensive analysis for global Bi-Specific Antibodies Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Bi-Specific Antibodies Therapy market size and forecasts, in consumption value ($ Million), 2018-2029
Global Bi-Specific Antibodies Therapy market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Bi-Specific Antibodies Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Bi-Specific Antibodies Therapy market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Bi-Specific Antibodies Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Bi-Specific Antibodies Therapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Amgen, Sanofi, Pfizer and Johnson & Johnson, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Bi-Specific Antibodies Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Fragment-Based Antibodies
IgG-Based Antibodies
Market segment by Application
Cancer
Haemophilia
Other Non-Cancer Diseases
Market segment by players, this report covers
Roche
Amgen
Sanofi
Pfizer
Johnson & Johnson
AstraZeneca
AbbVie
Lindis Biotech
MacroGenics, Inc
Genmab
Alphamab Co. Ltd
Akeso, Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Bi-Specific Antibodies Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Bi-Specific Antibodies Therapy, with revenue, gross margin and global market share of Bi-Specific Antibodies Therapy from 2018 to 2023.
Chapter 3, the Bi-Specific Antibodies Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Bi-Specific Antibodies Therapy market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Bi-Specific Antibodies Therapy.
Chapter 13, to describe Bi-Specific Antibodies Therapy research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Bi-Specific Antibodies Therapy
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Bi-Specific Antibodies Therapy by Type
- 1.3.1 Overview: Global Bi-Specific Antibodies Therapy Market Size by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 Global Bi-Specific Antibodies Therapy Consumption Value Market Share by Type in 2022
- 1.3.3 Fragment-Based Antibodies
- 1.3.4 IgG-Based Antibodies
- 1.4 Global Bi-Specific Antibodies Therapy Market by Application
- 1.4.1 Overview: Global Bi-Specific Antibodies Therapy Market Size by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Cancer
- 1.4.3 Haemophilia
- 1.4.4 Other Non-Cancer Diseases
- 1.5 Global Bi-Specific Antibodies Therapy Market Size & Forecast
- 1.6 Global Bi-Specific Antibodies Therapy Market Size and Forecast by Region
- 1.6.1 Global Bi-Specific Antibodies Therapy Market Size by Region: 2018 VS 2022 VS 2029
- 1.6.2 Global Bi-Specific Antibodies Therapy Market Size by Region, (2018-2029)
- 1.6.3 North America Bi-Specific Antibodies Therapy Market Size and Prospect (2018-2029)
- 1.6.4 Europe Bi-Specific Antibodies Therapy Market Size and Prospect (2018-2029)
- 1.6.5 Asia-Pacific Bi-Specific Antibodies Therapy Market Size and Prospect (2018-2029)
- 1.6.6 South America Bi-Specific Antibodies Therapy Market Size and Prospect (2018-2029)
- 1.6.7 Middle East and Africa Bi-Specific Antibodies Therapy Market Size and Prospect (2018-2029)
2 Company Profiles
- 2.1 Roche
- 2.1.1 Roche Details
- 2.1.2 Roche Major Business
- 2.1.3 Roche Bi-Specific Antibodies Therapy Product and Solutions
- 2.1.4 Roche Bi-Specific Antibodies Therapy Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 Roche Recent Developments and Future Plans
- 2.2 Amgen
- 2.2.1 Amgen Details
- 2.2.2 Amgen Major Business
- 2.2.3 Amgen Bi-Specific Antibodies Therapy Product and Solutions
- 2.2.4 Amgen Bi-Specific Antibodies Therapy Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 Amgen Recent Developments and Future Plans
- 2.3 Sanofi
- 2.3.1 Sanofi Details
- 2.3.2 Sanofi Major Business
- 2.3.3 Sanofi Bi-Specific Antibodies Therapy Product and Solutions
- 2.3.4 Sanofi Bi-Specific Antibodies Therapy Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 Sanofi Recent Developments and Future Plans
- 2.4 Pfizer
- 2.4.1 Pfizer Details
- 2.4.2 Pfizer Major Business
- 2.4.3 Pfizer Bi-Specific Antibodies Therapy Product and Solutions
- 2.4.4 Pfizer Bi-Specific Antibodies Therapy Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 Pfizer Recent Developments and Future Plans
- 2.5 Johnson & Johnson
- 2.5.1 Johnson & Johnson Details
- 2.5.2 Johnson & Johnson Major Business
- 2.5.3 Johnson & Johnson Bi-Specific Antibodies Therapy Product and Solutions
- 2.5.4 Johnson & Johnson Bi-Specific Antibodies Therapy Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 Johnson & Johnson Recent Developments and Future Plans
- 2.6 AstraZeneca
- 2.6.1 AstraZeneca Details
- 2.6.2 AstraZeneca Major Business
- 2.6.3 AstraZeneca Bi-Specific Antibodies Therapy Product and Solutions
- 2.6.4 AstraZeneca Bi-Specific Antibodies Therapy Revenue, Gross Margin and Market Share (2018-2023)
- 2.6.5 AstraZeneca Recent Developments and Future Plans
- 2.7 AbbVie
- 2.7.1 AbbVie Details
- 2.7.2 AbbVie Major Business
- 2.7.3 AbbVie Bi-Specific Antibodies Therapy Product and Solutions
- 2.7.4 AbbVie Bi-Specific Antibodies Therapy Revenue, Gross Margin and Market Share (2018-2023)
- 2.7.5 AbbVie Recent Developments and Future Plans
- 2.8 Lindis Biotech
- 2.8.1 Lindis Biotech Details
- 2.8.2 Lindis Biotech Major Business
- 2.8.3 Lindis Biotech Bi-Specific Antibodies Therapy Product and Solutions
- 2.8.4 Lindis Biotech Bi-Specific Antibodies Therapy Revenue, Gross Margin and Market Share (2018-2023)
- 2.8.5 Lindis Biotech Recent Developments and Future Plans
- 2.9 MacroGenics, Inc
- 2.9.1 MacroGenics, Inc Details
- 2.9.2 MacroGenics, Inc Major Business
- 2.9.3 MacroGenics, Inc Bi-Specific Antibodies Therapy Product and Solutions
- 2.9.4 MacroGenics, Inc Bi-Specific Antibodies Therapy Revenue, Gross Margin and Market Share (2018-2023)
- 2.9.5 MacroGenics, Inc Recent Developments and Future Plans
- 2.10 Genmab
- 2.10.1 Genmab Details
- 2.10.2 Genmab Major Business
- 2.10.3 Genmab Bi-Specific Antibodies Therapy Product and Solutions
- 2.10.4 Genmab Bi-Specific Antibodies Therapy Revenue, Gross Margin and Market Share (2018-2023)
- 2.10.5 Genmab Recent Developments and Future Plans
- 2.11 Alphamab Co. Ltd
- 2.11.1 Alphamab Co. Ltd Details
- 2.11.2 Alphamab Co. Ltd Major Business
- 2.11.3 Alphamab Co. Ltd Bi-Specific Antibodies Therapy Product and Solutions
- 2.11.4 Alphamab Co. Ltd Bi-Specific Antibodies Therapy Revenue, Gross Margin and Market Share (2018-2023)
- 2.11.5 Alphamab Co. Ltd Recent Developments and Future Plans
- 2.12 Akeso, Inc.
- 2.12.1 Akeso, Inc. Details
- 2.12.2 Akeso, Inc. Major Business
- 2.12.3 Akeso, Inc. Bi-Specific Antibodies Therapy Product and Solutions
- 2.12.4 Akeso, Inc. Bi-Specific Antibodies Therapy Revenue, Gross Margin and Market Share (2018-2023)
- 2.12.5 Akeso, Inc. Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Bi-Specific Antibodies Therapy Revenue and Share by Players (2018-2023)
- 3.2 Market Share Analysis (2022)
- 3.2.1 Market Share of Bi-Specific Antibodies Therapy by Company Revenue
- 3.2.2 Top 3 Bi-Specific Antibodies Therapy Players Market Share in 2022
- 3.2.3 Top 6 Bi-Specific Antibodies Therapy Players Market Share in 2022
- 3.3 Bi-Specific Antibodies Therapy Market: Overall Company Footprint Analysis
- 3.3.1 Bi-Specific Antibodies Therapy Market: Region Footprint
- 3.3.2 Bi-Specific Antibodies Therapy Market: Company Product Type Footprint
- 3.3.3 Bi-Specific Antibodies Therapy Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Bi-Specific Antibodies Therapy Consumption Value and Market Share by Type (2018-2023)
- 4.2 Global Bi-Specific Antibodies Therapy Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
- 5.1 Global Bi-Specific Antibodies Therapy Consumption Value Market Share by Application (2018-2023)
- 5.2 Global Bi-Specific Antibodies Therapy Market Forecast by Application (2024-2029)
6 North America
- 6.1 North America Bi-Specific Antibodies Therapy Consumption Value by Type (2018-2029)
- 6.2 North America Bi-Specific Antibodies Therapy Consumption Value by Application (2018-2029)
- 6.3 North America Bi-Specific Antibodies Therapy Market Size by Country
- 6.3.1 North America Bi-Specific Antibodies Therapy Consumption Value by Country (2018-2029)
- 6.3.2 United States Bi-Specific Antibodies Therapy Market Size and Forecast (2018-2029)
- 6.3.3 Canada Bi-Specific Antibodies Therapy Market Size and Forecast (2018-2029)
- 6.3.4 Mexico Bi-Specific Antibodies Therapy Market Size and Forecast (2018-2029)
7 Europe
- 7.1 Europe Bi-Specific Antibodies Therapy Consumption Value by Type (2018-2029)
- 7.2 Europe Bi-Specific Antibodies Therapy Consumption Value by Application (2018-2029)
- 7.3 Europe Bi-Specific Antibodies Therapy Market Size by Country
- 7.3.1 Europe Bi-Specific Antibodies Therapy Consumption Value by Country (2018-2029)
- 7.3.2 Germany Bi-Specific Antibodies Therapy Market Size and Forecast (2018-2029)
- 7.3.3 France Bi-Specific Antibodies Therapy Market Size and Forecast (2018-2029)
- 7.3.4 United Kingdom Bi-Specific Antibodies Therapy Market Size and Forecast (2018-2029)
- 7.3.5 Russia Bi-Specific Antibodies Therapy Market Size and Forecast (2018-2029)
- 7.3.6 Italy Bi-Specific Antibodies Therapy Market Size and Forecast (2018-2029)
8 Asia-Pacific
- 8.1 Asia-Pacific Bi-Specific Antibodies Therapy Consumption Value by Type (2018-2029)
- 8.2 Asia-Pacific Bi-Specific Antibodies Therapy Consumption Value by Application (2018-2029)
- 8.3 Asia-Pacific Bi-Specific Antibodies Therapy Market Size by Region
- 8.3.1 Asia-Pacific Bi-Specific Antibodies Therapy Consumption Value by Region (2018-2029)
- 8.3.2 China Bi-Specific Antibodies Therapy Market Size and Forecast (2018-2029)
- 8.3.3 Japan Bi-Specific Antibodies Therapy Market Size and Forecast (2018-2029)
- 8.3.4 South Korea Bi-Specific Antibodies Therapy Market Size and Forecast (2018-2029)
- 8.3.5 India Bi-Specific Antibodies Therapy Market Size and Forecast (2018-2029)
- 8.3.6 Southeast Asia Bi-Specific Antibodies Therapy Market Size and Forecast (2018-2029)
- 8.3.7 Australia Bi-Specific Antibodies Therapy Market Size and Forecast (2018-2029)
9 South America
- 9.1 South America Bi-Specific Antibodies Therapy Consumption Value by Type (2018-2029)
- 9.2 South America Bi-Specific Antibodies Therapy Consumption Value by Application (2018-2029)
- 9.3 South America Bi-Specific Antibodies Therapy Market Size by Country
- 9.3.1 South America Bi-Specific Antibodies Therapy Consumption Value by Country (2018-2029)
- 9.3.2 Brazil Bi-Specific Antibodies Therapy Market Size and Forecast (2018-2029)
- 9.3.3 Argentina Bi-Specific Antibodies Therapy Market Size and Forecast (2018-2029)
10 Middle East & Africa
- 10.1 Middle East & Africa Bi-Specific Antibodies Therapy Consumption Value by Type (2018-2029)
- 10.2 Middle East & Africa Bi-Specific Antibodies Therapy Consumption Value by Application (2018-2029)
- 10.3 Middle East & Africa Bi-Specific Antibodies Therapy Market Size by Country
- 10.3.1 Middle East & Africa Bi-Specific Antibodies Therapy Consumption Value by Country (2018-2029)
- 10.3.2 Turkey Bi-Specific Antibodies Therapy Market Size and Forecast (2018-2029)
- 10.3.3 Saudi Arabia Bi-Specific Antibodies Therapy Market Size and Forecast (2018-2029)
- 10.3.4 UAE Bi-Specific Antibodies Therapy Market Size and Forecast (2018-2029)
11 Market Dynamics
- 11.1 Bi-Specific Antibodies Therapy Market Drivers
- 11.2 Bi-Specific Antibodies Therapy Market Restraints
- 11.3 Bi-Specific Antibodies Therapy Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
- 11.5 Influence of COVID-19 and Russia-Ukraine War
- 11.5.1 Influence of COVID-19
- 11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
- 12.1 Bi-Specific Antibodies Therapy Industry Chain
- 12.2 Bi-Specific Antibodies Therapy Upstream Analysis
- 12.3 Bi-Specific Antibodies Therapy Midstream Analysis
- 12.4 Bi-Specific Antibodies Therapy Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Bi-Specific Antibodies Therapy. Industry analysis & Market Report on Bi-Specific Antibodies Therapy is a syndicated market report, published as Global Bi-Specific Antibodies Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Bi-Specific Antibodies Therapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
